研究者詳細 - 阪本　考司

論文 - 阪本　考司

分割表示 89 件中 41 - 60 件目／全件表示 >>

Performance of the St George's Respiratory Questionnaire in patients with connective tissue disease-associated interstitial lung disease 査読有り国際誌

Suzuki Atsushi, Kondoh Yasuhiro, Swigris Jeffrey J., Ando Masahiko, Kimura Tomoki, Kataoka Kensuke, Yamano Yasuhiko, Furukawa Taiki, Numata Mari, Sakamoto Koji, Hasegawa Yoshinori

RESPIROLOGY 23 巻 ( 9 ) 頁： 851 - 859 2018年9月

Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study

Suzuki Atsushi, Taniguchi Hiroyuki, Ando Masahiko, Kondoh Yasuhiro, Kimura Tomoki, Kataoka Kensuke, Matsuda Toshiaki, Yokoyama Toshiki, Sakamoto Koji, Hasegawa Yoshinori

CLINICAL RESPIRATORY JOURNAL 12 巻 ( 3 ) 頁： 895 - 903 2018年3月

Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study 査読有り

Hashimoto Naozumi, Ando Akira, Iwano Shingo, Sakamoto Koji, Okachi Shotaro, Matsuzaki Asuka, Okada Yu, Wakai Kenji, Yokoi Kohei, Hasegawa Yoshinori

BMC PULMONARY MEDICINE 18 巻 ( 1 ) 頁： 2 2018年1月

A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis

Furukawa Taiki, Kondoh Yasuhiro, Taniguchi Hiroyuki, Yagi Mitsuaki, Matsuda Toshiaki, Kimura Tomoki, Kataoka Kensuke, Johkoh Takeshi, Ando Masahiko, Hashimoto Naozumi, Sakamoto Koji, Hasegawa Yoshinori

EUROPEAN RESPIRATORY JOURNAL 51 巻 ( 1 ) 2018年1月

Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma 査読有り国際誌

Sakamoto Koji, Ito Satoru, Hashimoto Naozumi, Hasegawa Yoshinori

BMC CANCER 17 巻 ( 1 ) 頁： 526 2017年8月

Aging Impairs Alveolar Macrophage Phagocytosis and Increases Influenza-Induced Mortality in Mice. 査読有り国際誌

Wong CK, Smith CA, Sakamoto K, Kaminski N, Koff JL, Goldstein DR

Journal of immunology (Baltimore, Md. : 1950) 199 巻 ( 3 ) 頁： 1060 - 1068 2017年8月

Modified mesenchymal stem cells using miRNA transduction alter lung injury in a bleomycin model. 査読有り国際誌

Huleihel L, Sellares J, Cardenes N, Álvarez D, Faner R, Sakamoto K, Yu G, Kapetanaki MG, Kaminski N, Rojas M

American journal of physiology. Lung cellular and molecular physiology 313 巻 ( 1 ) 頁： L92 - L103 2017年7月

Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction 査読有り国際誌

Teramachi Ryo, Taniguchi Hiroyuki, Kondoh Yasuhiro, Ando Masahiko, Kimura Tomoki, Kataoka Kensuke, Suzuki Atsushi, Furukawa Taiki, Sakamoto Koji, Hasegawa Yoshinori

RESPIROLOGY 22 巻 ( 5 ) 頁： 986 - 990 2017年7月

COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study. 査読有り

Matsuda T, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, Sakamoto K, Suzuki A, Furukawa T, Hasegawa Y

Respirology (Carlton, Vic.) 22 巻 ( 4 ) 頁： 721-727 2017年5月

Soluble thrombomodulin in bronchoalveolar lavage fluid is an independent predictor of severe drug-induced lung injury 査読有り国際誌

Suzuki Atsushi, Taniguchi Hiroyuki, Kondoh Yasuhiro, Ando Masahiko, Watanabe Naohiro, Kimura Tomoki, Kataoka Kensuke, Yokoyama Toshiki, Sakamoto Koji, Hasegawa Yoshinori

RESPIROLOGY 22 巻 ( 4 ) 頁： 744 - 749 2017年5月

Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis. 査読有り国際誌

Tzouvelekis A, Herazo-Maya JD, Slade M, Chu JH, Deiuliis G, Ryu C, Li Q, Sakamoto K, Ibarra G, Pan H, Gulati M, Antin-Ozerkis D, Herzog EL, Kaminski N

Respirology (Carlton, Vic.) 22 巻 ( 3 ) 頁： 486 - 493 2017年4月

Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study 査読有り国際誌

Fukihara, J; Taniguchi, H; Ando, M; Kondoh, Y; Kimura, T; Kataoka, K; Furukawa, T; Johkoh, T; Fukuoka, J; Sakamoto, K; Hasegawa, Y

BMC PULMONARY MEDICINE 17 巻 ( 1 ) 頁： 30 2017年2月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：BMC Pulmonary Medicine

Background: Increases in hemosiderin-laden macrophages (HLM) are reported to be observed in idiopathic pulmonary fibrosis (IPF). According to a recent study, significant correlation between hemosiderin deposition in the lung tissue of IPF and pulmonary hypertension evaluated by echocardiography has been suspected. In this study, we aimed to evaluate whether HLM in bronchoalveolar lavage fluid (BALF) is a factor correlated with pulmonary hemodynamic parameters evaluated by right heart catheterization in patients with IPF. Methods: Initial data from 103 consecutive patients with IPF who underwent surgical lung biopsy between November 2007 and March 2014 were retrospectively analyzed. The "HLM score" of BALF was established by dividing the number of Perls' Prussian blue stain positive macrophages by the total number of macrophages counted. Results: BALF showed an elevated HLM score (38.2%). Right heart catheterization revealed mean pulmonary arterial pressure (mPAP) of 16.3mmHg and pulmonary vascular resistance (PVR) of 1.55 Wood units. HLM score was positively correlated with mPAP (ρ=0.204; p=0.038) and PVR (ρ=0.349, p<0.001). In multivariate analysis, 6-min walk distance (standardized partial regression coefficient [β], 0.391; p<0.001), minimum oxygen saturation during 6-min walk distance (β, 0.294; p=0.001) and HLM score (β, 0.265; p=0.002) were independently correlated with PVR. Conclusions: HLM score in BALF is an independent factor correlated with PVR in patients with IPF.

DOI： 10.1186/s12890-017-0376-8

Web of Science

Scopus

PubMed

SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis. 査読有り国際共著国際誌

Tzouvelekis A, Yu G, Lino Cardenas CL, Herazo-Maya JD, Wang R, Woolard T, Zhang Y, Sakamoto K, Lee H, Yi JS, DeIuliis G, Xylourgidis N, Ahangari F, Lee PJ, Aidinis V, Herzog EL, Homer R, Bennett AM, Kaminski N

American journal of respiratory and critical care medicine 195 巻 ( 4 ) 頁： 500 - 514 2017年2月

The St. George's Respiratory Questionnaire as a prognostic factor in IPF 査読有り国際誌

Furukawa Taiki, Taniguchi Hiroyuki, Ando Masahiko, Kondoh Yasuhiro, Kataoka Kensuke, Nishiyama Osamu, Johkoh Takeshi, Fukuoka Junya, Sakamoto Koji, Hasegawa Yoshinori

RESPIRATORY RESEARCH 18 巻 ( 1 ) 頁： 18 2017年1月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：Respiratory Research

Background: It is unclear whether health related quality of life (HRQL) may have a predictive value for mortality in idiopathic pulmonary fibrosis (IPF). We investigated the relationship between HRQL assessed using the St. George's Respiratory Questionnaire (SGRQ) and survival time in patients with IPF, and tried to determine a clinical meaningful cut off value to predict poorer survival rates. Methods: We retrospectively analyzed consecutive patients with IPF who underwent an initial evaluation from May 2007 to December 2012. The diagnosis of IPF was made according to the 2011 international consensus guidelines. We used Cox proportional hazard models to identify independent predictors for mortality rate in patients with IPF. Results: We examined 182 eligible cases, average age was 66years old, and 86% were male. Mean levels of percent predicted FVC, DLco, six-minute-walk test distance, and the SGRQ total score were around 80%, 58%, 580m, and 34 points. On multivariate analysis, the SGRQ total score (hazard ratio [HR], 1.012; 95% confidence interval [CI] 1.001-1.023; P=<.029) and percent predicted FVC (HR, 0.957; 95% CI 0.944-0.971, P<.001) were independent predictors for mortality rate. Moreover, a score higher than 30 points in the SGRQ total score showed higher mortality rate (HR, 2.047; 95% CI, 1.329-3.153; P=<.001). Conclusions: The SGRQ total score was one of independent prognostic factors in patients with IPF. Total scores higher than 30 points were associated with higher mortality rates. Trial registration: This study was retrospective, observational study, so it is not applicable.

DOI： 10.1186/s12931-017-0503-3

Web of Science

Scopus

PubMed

Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia. 査読有り

Nakahara Y, Taniguchi H, Kimura T, Kondoh Y, Arizono S, Nishimura K, Sakamoto K, Ito S, Ando M, Hasegawa Y

Respirology (Carlton, Vic.) 22 巻 ( 1 ) 頁： 120-125 2017年1月

Exogenous induction of unphosphorylated PTEN reduces TGFβ-induced extracellular matrix expressions in lung fibroblasts. 査読有り

25 巻 ( 1 ) 頁： 86-97 2017年1月

Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis. 査読有り

Matsuda T, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, Nishimura K, Nishiyama O, Sakamoto K, Hasegawa Y

Internal medicine (Tokyo, Japan) 56 巻 ( 13 ) 頁： 1637-1644 2017年

Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy

Omote, N; Hashimoto, N; Morise, M; Sakamoto, K; Miyazaki, S; Ando, A; Nakahara, Y; Hasegawa, Y

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 巻頁： 3541 - 3547 2017年

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：International Journal of COPD

Background: Non-small cell lung cancer (NSCLC) is the predominant cause of death in patients with COPD, and the severity of COPD in NSCLC patients is classified mainly as mild to moderate. Most advanced NSCLC patients with mild to moderate COPD are treated with chemotherapy; however, the feasibility for and prognosis after chemotherapy of these patients are not well understood. The aim of this study was to elucidate the impact of mild to moderate COPD on the feasibility for and prognosis after chemotherapy in NSCLC patients. Patients and methods: A retrospective review was performed on 268 NSCLC patients who received first-line chemotherapy from 2009 to 2014 in our institution. Finally, 85 evaluable patients were included in this study. The clinical characteristics, toxicity profile, objective response rate, and prognosis were analyzed and compared between patients with mild to moderate COPD and those without COPD (non-COPD). Results: Forty-three patients were classified as COPD (27 cases mild and 16 cases moderate) and 42 patients as non-COPD. The COPD group were older and had fewer never-smokers than the non-COPD group. The objective response rate did not differ between groups (p=0.14). There was no significant difference in overall survival between COPD and non-COPD groups (15.0 and 17.0 months, log-rank test p=0.57). In the multivariate Cox’s proportional hazard model, the adjusted hazard ratio (HRadj) was statistically significant for male sex (HRadj =5.382, 95% CI: 1.496–19.359; p=0.010), pathological diagnosis of adenocarcinoma (HRadj =0.460, 95% CI: 0.223–0.948; p=0.035), and epithelial growth factor receptor negative mutation (HRadj =6.040, 95% CI: 1.158–31.497; p=0.033), but not for the presence of COPD (HRadj =0.661, 95% CI: 0.330–1.325; p=0.24). Toxicity profile in COPD group was favorable, as in the non-COPD group. Conclusion: Mild to moderate COPD did not have a significant deleterious impact on toxicity and prognosis in NSCLC patients.

DOI： 10.2147/COPD.S149456

Web of Science

Scopus

PubMed

PULMONARY REHABILITATION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: COMPARISON WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 査読有り

Arizono Shinichi, Taniguchi Hiroyuki, Sakamoto Koji, Kondoh Yasuhiro, Kimura Tomoki, Kataoka Kensuke, Ogawa Tomoya, Watanabe Fumiko, Tabira Kazuyuki, Kozu Ryo

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES 34 巻 ( 4 ) 頁： 283 - 289 2017年

Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: comparison with chronic obstructive pulmonary disease. 査読有り国際誌

Arizono S, Taniguchi H, Sakamoto K, Kondoh Y, Kimura T, Kataoka K, Ogawa T, Watanabe F, Tabira K, Kozu R

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 34 巻 ( 4 ) 頁： 283 - 289 2017年

　前のページ - 次のページ　

<阪本 考司>

論文 - 阪本 考司

<阪本　考司>

論文 - 阪本　考司